<?xml version="1.0" encoding="UTF-8"?>
<ref id="B122-molecules-25-02796">
 <label>122.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Calland</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Albecka</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Belouzard</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Wychowski</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Duverlie</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Descamps</surname>
    <given-names>V.</given-names>
   </name>
   <name>
    <surname>Hober</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Dubuisson</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Rouillé</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Séron</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>(−)-Epigallocatechin-3-gallate is a new inhibitor of hepatitis C virus entry</article-title>
  <source>Hepatology</source>
  <year>2012</year>
  <volume>55</volume>
  <fpage>720</fpage>
  <lpage>729</lpage>
  <pub-id pub-id-type="doi">10.1002/hep.24803</pub-id>
  <pub-id pub-id-type="pmid">22105803</pub-id>
 </element-citation>
</ref>
